The Diagnosis and Management of Atrial Fibrillation in Primary Care (Webinar Summary)
In the recent webinar, ‘Diagnosing & Managing Atrial Fibrillation in Primary Care,’ Dr. Yassir Javaid highlighted the critical issue of AFib management in a primary care setting.
In our recent webinar on “The Diagnosis and Management of Atrial Fibrillation in Primary Care: Latest Guidance and Embracing Innovation”, Dr Yassir Javaid introduced the urgency of the misdiagnosis of one of the most common cardiovascular conditions, atrial fibrillation. AF is a leading risk factor for stroke, responsible for at least 25% of all strokes worldwide. Accurate diagnosis and management of AF are essential for improving patient outcomes and preventing life-threatening complications. The webinar highlighted how AI-powered technology, such as our clinical assistant PMcardio, can significantly improve the diagnosis and management of AF in primary care settings.
Traditional AF Diagnosis Challenges in Primary Care Settings
Primary care professionals traditionally diagnose AF by checking a patient’s pulse and taking an ECG. However, especially for healthcare professionals not specialised in cardiology, such as GPs, nurses and paramedics, ECG interpretation can be challenging, leading to inaccuracies and potential misdiagnoses. The increasing prevalence of AF, particularly in the aging population, necessitates a more reliable solution for early detection and effective treatment.
PMcardio: A Revolutionary Solution for Enhanced Atrial Fibrillation Diagnosis
The webinar introduced PMcardio as a solution, that has the potential to enhance AF diagnosis and management at the first point of contact. Easily accessible in the form of a smartphone application, PMcardio enables any healthcare professional to diagnose and treat 38 cardiovascular diseases with the precision of a cardiologist. Not only does the CE-certified Class IIb medical device empower medical prod to interpret ECGs and identify cardiac conditions more accurately – it also generates guideline-adherent treatment recommendations personalised for each patient. The integration of an innovative solution, such as PMcardio can significantly improve clinical decision-making, quality of care and outcomes of patients suffering from heart disease.
Independent Study Validates PMcardio’s Exceptional Performance in AF Detection
Dr. Jelle Himmelreich presented the results of an independent validation study conducted in the Netherlands, demonstrating PMcardio’s excellent sensitivity and specificity for detecting atrial fibrillation or atrial flutter and its outstanding performance in detecting major ECG abnormalities. These findings spotlight the potential of the app as a valuable tool for primary care practitioners, facilitating early detection and treatment of AF and associated complications.
Embracing AI-Powered Solutions for Improved Atrial Fibrillation Management
Adopting innovative AI-powered solutions like the PMcardio app can significantly improve the diagnosis and management of atrial fibrillation in primary care settings. By providing accurate ECG interpretation and tailored patient management recommendations, these technologies can help healthcare professionals make better-informed decisions, leading to improved patient care and outcomes. As the prevalence of AF continues to rise, the integration of such innovative solutions in frontline healthcare practices is crucial to minimize the risk of life-threatening strokes and other complications associated with atrial fibrillation.
If you weren’t able to attend our webinar, don’t worry – you can still catch up on all the valuable insights by watching the recording on our YouTube channel:
We invite you to try our AI-powered certified medical device, PMcardio, for free by registering via this link: pmcardio.powerfulmedical.com
For those who are not located in Europe, we would like to kindly invite you to join our waiting list, and we will get back to you, once PMcardio is available in your region: share-eu1.hsforms.com/1CrZoKznPSuqmvphdZ3Isowfyfsg
Share this article
About PMcardio
PMcardio is a CE-marked Class IIb AI medical device that interprets any 12-lead ECG — from a photo or a digital file — in seconds. It detects 50+ ECG findings, including occlusion myocardial infarction (OMI) — the acute coronary occlusions that conventional STEMI criteria miss in over half of cases. Its Queen of Hearts™ OMI model holds FDA Breakthrough Device Designation, and PMcardio is already used by 100,000+ clinicians who have analyzed more than 2.5 million ECGs.
About Powerful Medical
Powerful Medical is a medical-technology company using artificial intelligence to transform how cardiovascular disease — the world’s leading cause of death — is diagnosed. Founded in 2017, it built PMcardio, the world’s first AI medical device to detect acute coronary occlusion (OMI) from an ECG. Its research is published in the European Heart Journal – Digital Health and validated across 25+ clinical studies, and its Queen of Hearts™ model earned FDA Breakthrough Device Designation. To date, PMcardio has supported the detection of 120,000+ heart attacks across 150+ hospital deployments worldwide.
